We show here that TLR4 and TLR9 signaling downregulated BCMA in MM cells at both the gene and protein levels and that approximately 50% of patients’ myeloma cells also respond to TLR activation by downregulating BCMA. Here, TNFRSF17 is linked to plasma cell myeloma.